TSS
PDSB icon

Two Sigma Securities’s PDS Biotechnology PDSB Stock Holding History

Two Sigma Securities’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19K Buy
+31,481
New +$23.7K ﹤0.01% 1376
2025
Q4 		– Sell
-14,149
Closed -$14.3K – 1883
2025
Q3 		$14.3K Sell
14,149
-8,479
-37% -$9.97K ﹤0.01% 1180
2025
Q2 		$30.1K Buy
+22,628
New +$30.7K ﹤0.01% 1153
2019
Q1 		– Sell
-1,222
Closed -$8K – 2279
2018
Q4 		$8K Buy
+1,222
New +$16.2K ﹤0.01% 2036

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's PDSB Position: Q1 2026 in Review

Two Sigma Securities opened a new position in PDS Biotechnology (PDSB) in Q1 2026: 31,481 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #1376 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PDSB as recently as Q3 2025.

Two Sigma Securities first reported a position in PDSB in Q4 2018 and has held it in 4 quarters since. The position peaked at $30.1K in Q2 2025. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Two Sigma Securities held 31,481 shares of PDS Biotechnology worth $19K as of Q1 2026.
  • PDS Biotechnology was a new Two Sigma Securities position in Q1 2026.
  • PDS Biotechnology made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1376 holding.
  • Two Sigma Securities first reported a position in PDS Biotechnology in Q4 2018 and has held it in 4 quarters since.
  • Two Sigma Securities's PDS Biotechnology position peaked at $30.1K in Q2 2025.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.